The Future for Biotech Funding
We hear from funders in our ecosystem about what’s on the horizon for investment in the region’s biotechnology and life sciences sector. You will take away insights on activity, growth and opportunity throughout the capital stack, from a variety of perspectives.
- Bob Creeden, managing director, UVA LVG Seed Fund & New Ventures
- Paul Nolde, president, CAV Angels
- Bret Schreiber, vice president, life Sciences and technology, Fulton Bank